Is Wall Street Bullish or Bearish on Keurig Dr Pepper Stock?

With a market cap of $46.7 billion, Keurig Dr Pepper Inc. (KDP) owns, manufactures, and distributes beverages and single-serve brewing systems in the United States and internationally. Founded in 1981, the Burlington, Massachusetts-based company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International.Shares of the beverage giant have underperformed the broader market over the past year. KDP stock has surged 2.5% over the past 52 weeks and 7.1% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 12.3% over the past year but has dropped 3.3% in 2025.Narrowing the focus, KDP has outperformed the Nasdaq Food & Beverage ETF’s (FTXG) 6.8% decline over the past 52 weeks and a marginal dip this year. www.barchart.com KDP shares declined 2.1% following the release of its Q1 earnings on Apr 24. The company reported a 4.8% year-over-year growth in its revenue, which amounted to $3.6 billion and surpassed the analyst estimates. Moreover, its adjusted EBITDA came in at $1 billion, with an EBITDA margin of 28% and beating the analyst estimates by 2.9%. The company’s EPS came in at $0.42, beating the Street’s forecast by 10.5%.For the current year ending in December 2025, analysts predict KDP’s EPS will climb 6.3% year over year to $2.04. Moreover, the company has surpassed or met analysts’ consensus estimates in each of the past four quarters.Among the 18 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 12 “Strong Buy” ratings, one “Moderate Buy,” and five “Holds.” www.barchart.com This configuration is more bullish than a month ago, when the stock had 10 “Strong Buy” ratings.On Apr. 24, Barclays PLC (BCS) analyst Lauren Lieberman maintained a “Buy” rating on KDP stock and increased the price target from $37 to $38.While KDP currently hovers above its mean price target of $39.10, its Street-high of $42 suggests a 22.1% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.